308 related articles for article (PubMed ID: 21481985)
1. Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents.
Kumar D; Patel G; Chavers AK; Chang KH; Shah K
Eur J Med Chem; 2011 Jul; 46(7):3085-92. PubMed ID: 21481985
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective Synthesis, Synthetic and Pharmacological Application of Monoterpene-Based 1,2,4- and 1,3,4-Oxadiazoles.
Gonda T; Bérdi P; Zupkó I; Fülöp F; Szakonyi Z
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283373
[TBL] [Abstract][Full Text] [Related]
4. Efficient access to novel androsteno-17-(1',3',4')-oxadiazoles and 17β-(1',3',4')-thiadiazoles via N-substituted hydrazone and N,N'-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro.
Kovács D; Wölfling J; Szabó N; Szécsi M; Minorics R; Zupkó I; Frank É
Eur J Med Chem; 2015 Jun; 98():13-29. PubMed ID: 25993309
[TBL] [Abstract][Full Text] [Related]
5. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
Kumar D; Sundaree S; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety.
Zhang K; Wang P; Xuan LN; Fu XY; Jing F; Li S; Liu YM; Chen BQ
Bioorg Med Chem Lett; 2014 Nov; 24(22):5154-6. PubMed ID: 25442303
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
Bondock S; Adel S; Etman HA; Badria FA
Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
Du K; Cao X; Zhang P; Zheng H
Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents.
Gurupadaswamy HD; Girish V; Kavitha CV; Raghavan SC; Khanum SA
Eur J Med Chem; 2013 May; 63():536-43. PubMed ID: 23535322
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides.
Avanzo RE; Padrón JM; D'Accorso NB; Fascio ML
Bioorg Med Chem Lett; 2017 Aug; 27(16):3674-3677. PubMed ID: 28716494
[TBL] [Abstract][Full Text] [Related]
18. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
Khalil NA; Kamal AM; Emam SH
Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]